Open Government Portal

About this information

Open data is defined as structured data that is machine-readable, freely shared, used and built on without restrictions.

The key things to remember about open data are:

  • #Availability and access#: the data must be available as a whole and at no more than a reasonable reproduction cost, preferably by downloading over the internet. The data must also be available in a convenient and modifiable form.
  • #Re-use and redistribution#: the data must be provided under terms that permit re-use and redistribution including the intermixing with other datasets.
  • #Universal participation#: everyone must be able to use, re-use and redistribute. There should be no discrimination against fields of endeavour or against persons or groups. For example, 'non-commercial' restrictions that would prevent 'commercial' use, or restrictions of use for certain purposes (e.g. only in education), are not allowed.
Found 47212 records

The Health Canada and Health Technology Assessment (HTA) review processes are independent of each other. Aligned reviews project will make …

Record Modified: Sep 17, 2020
Record Released: Sep 17, 2020
Publisher: Health Canada
Formats: HTML
Keywords: Aligned reviews Health Canada and Health Technology Assessment.

These amendments would introduce a regulatory framework for Drug Shortages within the Food and Drug Regulations.

Record Modified: Sep 17, 2020
Record Released: Sep 17, 2020
Publisher: Health Canada
Formats: HTML
Keywords: Forward Regulatory Plan public list anticipated regulatory changes or actions Development of regulations planned and potential regulatory initiatives identifies public consultation opportunities departmental contact point

Below are some of the unique features of Canada's Access to Medicines Regime, many of which resulted from negotiations between …

Record Modified: Sep 17, 2020
Record Released: Sep 17, 2020
Publisher: Health Canada
Formats: HTML
Keywords: Canada's Access to Medicines Regime World Trade Organization negotiations between the Government of Canada the private sector and non-governmental organizations.

It presents WTO-Member Countries and Non-WTO Member Countries Eligible to Import Under the Regime.

Record Modified: Sep 17, 2020
Record Released: Sep 17, 2020
Publisher: Health Canada
Formats: HTML
Keywords: Canada's Access to Medicines Regime WTO-member countries non-WTO member countries countries eligible to import under the Regime.

It presents the list Least-Developed Countries Eligible to Import Under the Regime.

Record Modified: Sep 17, 2020
Record Released: Sep 17, 2020
Publisher: Health Canada
Formats: HTML
Keywords: Canada's Access to Medicines Regime Least-developed countries countries eligible to import under the Regime.

To participate in the Regime, an eligible importing country must declare that it has insufficient or no pharmaceutical manufacturing capacity …

Record Modified: Sep 17, 2020
Record Released: Sep 17, 2020
Publisher: Health Canada
Formats: HTML
Keywords: Canada's Access to Medicines Regime manufacturing capacity eligible importing country insufficient or no pharmaceutical manufacturing capacity.

Canada's Access to Medicines Regime includes a number of measures to prevent diversion of drugs and medical devices to unintended …

Record Modified: Sep 17, 2020
Record Released: Sep 17, 2020
Publisher: Health Canada
Formats: HTML
Keywords: Canada's Access to Medicines Regime Anti-diversionary measures prevent diversion of drugs and medical devices unintended markets.

The Government of Canada regards non-governmental organizations (NGOs) as valuable resources and actively consulted with them when designing Canada's Access …

Record Modified: Sep 17, 2020
Record Released: Sep 17, 2020
Publisher: Health Canada
Formats: HTML
Keywords: Canada's Access to Medicines Regime role of Non-Governmental Organizations

Instructions for complying with the Requirements of Canada's Access to Medicines Regime specify how to notify the World Trade Organization …

Record Modified: Sep 17, 2020
Record Released: Sep 17, 2020
Publisher: Health Canada
Formats: HTML
Keywords: Canada's Access to Medicines Regime comply with procedures requirements of Canada's Access to Medicines Regime addition of a particular drug or medical device to the list of eligible products.

The patent holder may seek an order from the Federal Court of Canada to terminate a compulsory licence, if the …

Record Modified: Sep 17, 2020
Record Released: Sep 17, 2020
Publisher: Health Canada
Formats: HTML
Keywords: Canada's Access to Medicines Regime termination of authorization terminate a compulsory licence patent holder Federal Court of Canada.